Recombinant influenza vectors with a polII promoter and ribozymes for vaccines and gene therapy
US7723094B2 · kind B2 · utility
19Cited by
3References
42Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 27, 2004 |
| Grant date | May 25, 2010 |
| Priority date | — |
| Expiry date | May 27, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a composition useful to prepare influenza viruses, e.g., in the absence of helper virus, using vectors which include PolII promoters and multiple ribozyme sequences.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.